Similarly, immunohistochemical (IHC) markers of prognostic significance that are frequently used for BC are estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her2/neu). This evidence concerns the gene ERBB2 and breast cancer.